BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 25326741)

  • 1. Risk of cerebrovascular events in patients with patent foramen ovale and intracardiac devices.
    Poddar KL; Nagarajan V; Krishnaswamy A; Bajaj NS; Kumari M; Bdair H; Modi D; Agarwal S; Goel SS; Parashar A; Tuzcu EM; Kapadia SR
    JACC Cardiovasc Interv; 2014 Nov; 7(11):1221-6. PubMed ID: 25326741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stroke or transient ischemic attack in patients with transvenous pacemaker or defibrillator and echocardiographically detected patent foramen ovale.
    DeSimone CV; Friedman PA; Noheria A; Patel NA; DeSimone DC; Bdeir S; Aakre CA; Vaidya VR; Slusser JP; Hodge DO; Ackerman MJ; Rabinstein AA; Asirvatham SJ
    Circulation; 2013 Sep; 128(13):1433-41. PubMed ID: 23946264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism.
    Wahl A; Jüni P; Mono ML; Kalesan B; Praz F; Geister L; Räber L; Nedeltchev K; Mattle HP; Windecker S; Meier B
    Circulation; 2012 Feb; 125(6):803-12. PubMed ID: 22238228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent events after percutaneous closure of patent foramen ovale.
    Wallenborn J; Bertog SC; Franke J; Steinberg DH; Majunke N; Wilson N; Wunderlich N; Sievert H
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):541-6. PubMed ID: 22707325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of cardiac implantable electronic device and patent foramen ovale in ischemic stroke: A case-only study.
    Agboola KM; Lee JM; Liu X; Novak E; Cuculich PS; Cooper DH; Noheria A
    Pacing Clin Electrophysiol; 2019 Mar; 42(3):341-348. PubMed ID: 30620091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischemic stroke and patent foramen ovale: risk factors and genetic profile.
    Lantz M; Sjöstrand C; Kostulas K
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):841-5. PubMed ID: 22784820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low cerebrovascular event rate in subjects with patent foramen ovale and different clinical presentations: results from a prospective non randomized study on a population including patients with and without patent foramen ovale closure.
    Faggiano P; Frattini S; Piovesana P; Lorusso R; Chiari E; Scolari F; Padovani A; Cas LD
    Int J Cardiol; 2012 Apr; 156(1):47-52. PubMed ID: 21112103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent stroke in patients with patent foramen ovale: An observational prospective study of percutaneous closure of PFO versus non-closure.
    Mirzada N; Ladenvall P; Hansson PO; Eriksson P; Dellborg M
    Int J Cardiol; 2015 Sep; 195():293-9. PubMed ID: 26056962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent events following patent foramen ovale closure in patients above 55 years of age with presumed paradoxical embolism.
    Spies C; Khandelwal A; Timmemanns I; Kavinsky CJ; Schräder R; Hijazi ZM
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):966-70. PubMed ID: 18942060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial fibrillation following device closure of patent foramen ovale.
    Burow A; Schwerzmann M; Wallmann D; Tanner H; Sakata T; Windecker S; Meier B; Delacrétaz E
    Cardiology; 2008; 111(1):47-50. PubMed ID: 18239392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stroke and patent foramen ovale in young individuals.
    Piechowski-Jozwiak B; Bogousslavsky J
    Eur Neurol; 2013; 69(2):108-17. PubMed ID: 23207510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocardial Device Leads in Patients with Patent Foramen Ovale: Echocardiographic Correlates of Stroke/TIA and Mortality.
    Ponamgi SP; Vaidya VR; Desimone CV; Noheria A; Hodge DO; Slusser JP; Ammash NM; Bruce CJ; Rabinstein AA; Friedman PA; Asirvatham SJ
    Pacing Clin Electrophysiol; 2017 Mar; 40(3):310-322. PubMed ID: 27943333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of hematoma complications after device implant in the clopidogrel era.
    Kutinsky IB; Jarandilla R; Jewett M; Haines DE
    Circ Arrhythm Electrophysiol; 2010 Aug; 3(4):312-8. PubMed ID: 20558847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patent foramen ovale closure using a bioabsorbable closure device: safety and efficacy at 6-month follow-up.
    Van den Branden BJ; Post MC; Plokker HW; ten Berg JM; Suttorp MJ
    JACC Cardiovasc Interv; 2010 Sep; 3(9):968-73. PubMed ID: 20850098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and repair of intraoperatively diagnosed patent foramen ovale and association with perioperative outcomes and long-term survival.
    Krasuski RA; Hart SA; Allen D; Qureshi A; Pettersson G; Houghtaling PL; Batizy LH; Blackstone E
    JAMA; 2009 Jul; 302(3):290-7. PubMed ID: 19602688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent stroke and patent foramen ovale: a systematic review and meta-analysis.
    Katsanos AH; Spence JD; Bogiatzi C; Parissis J; Giannopoulos S; Frogoudaki A; Safouris A; Voumvourakis K; Tsivgoulis G
    Stroke; 2014 Nov; 45(11):3352-9. PubMed ID: 25293664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of atrial fibrillation after transcatheter closure of patent foramen ovale in patients with or without cryptogenic stroke.
    Bronzetti G; D'Angelo C; Donti A; Salomone L; Giardini A; Maria Picchio F; Boriani G
    Int J Cardiol; 2011 Jan; 146(1):17-21. PubMed ID: 19487038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patent foramen ovale increases the risk of acute ischemic stroke in patients with acute pulmonary embolism leading to right ventricular dysfunction.
    Goliszek S; Wiśniewska M; Kurnicka K; Lichodziejewska B; Ciurzyński M; Kostrubiec M; Gołębiowski M; Babiuch M; Paczynska M; Koć M; Palczewski P; Wyzgał A; Pruszczyk P
    Thromb Res; 2014 Nov; 134(5):1052-6. PubMed ID: 25282541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder.
    Kutty S; Brown K; Asnes JD; Rhodes JF; Latson LA
    Am J Cardiol; 2008 May; 101(10):1487-92. PubMed ID: 18471463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous closure of patent foramen ovale for cryptogenic stroke: a meta-analysis of randomized controlled trials.
    Kwong JS; Lam YY; Yu CM
    Int J Cardiol; 2013 Oct; 168(4):4132-8. PubMed ID: 23890879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.